Biomarkers for predicting serious cardiac outcomes at 72 hours in patients presenting early after chest pain onset with symptoms of acute coronary syndromes

Clinical Chemistry

Volumn 58, Issue 1, 2012, Pages 298-302

  Kavsak, Peter A ^a   Hill, Stephen A ^a   Supapol, Wendy Bhanich ^a   Devereaux, Philip J ^a   Worster, Andrew ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; CREATINE KINASE; CREATINE KINASE MB; INTERLEUKIN 6; ISCHEMIA MODIFIED ALBUMIN; TROPONIN I;

ACUTE CORONARY SYNDROME; ADULT; ADVERSE OUTCOME; AGED; AREA UNDER THE CURVE; ARTICLE; BIOASSAY; BLOOD SAMPLING; CONTROLLED STUDY; DEATH; DIAGNOSTIC TEST ACCURACY STUDY; EMERGENCY WARD; FOLLOW UP; HEART ARRHYTHMIA; HEART FAILURE; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; ONSET AGE; PREDICTION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; THORAX PAIN;

ACUTE CORONARY SYNDROME; AREA UNDER CURVE; ARRHYTHMIAS, CARDIAC; BIOLOGICAL MARKERS; CHEST PAIN; HEART FAILURE; HUMANS; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; ROC CURVE; TIME FACTORS;

EID: 84856074742     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2011.172064     Document Type: Article

References (20)

1. Thygesen K, Alpert JS, White HD, and on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. J Am Coll Cardiol 2007;50:2173-95.
2. Keller T, Zeller T, Peetz D, Tzikas S, Roth A, Czyz E, et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med 2009;361:868-77.
3. Reichlin T, Hochholzer W, Bassetti S, Steuer S, Stelzig C, Hartwiger S, et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 2009;361:858-67.
4. Bonaca M, Scirica B, Sabatine M, Dalby A, Spinar J, Murphy SA, et al. Prospective evaluation of the prognostic implications of improved assay performance with a sensitive assay for cardiac troponin I. J Am Coll Cardiol 2010;55:2118-24.
5. deFilippi CR, de Lemos JA, Christenson RH, Gottdiener JS, Kop WJ, Zhan M, Seliger SL. Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults. JAMA 2010;304:2494-502.
6. de Lemos JA, Drazner MH, Omland T, Ayers CR, Khera A, Rohatgi A, et al. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA 2010;304:2503-12.
7. Kavsak PA, Xu L, Yusuf S, McQueen MJ. High-sensitivity cardiac troponin I measurement for risk stratification in a stable high-risk population. Clin Chem 2011;57:1146-53.
8. de Lemos JA, Morrow DA, deFilippi CR. Highly sensitive troponin assays and the cardiology community: a love/hate relationship? Clin Chem 2011;57:826-9.
9. Kavsak PA, Allen LC, Apple FS, Booth RA, Chan PC, Delvin E, et al. Cardiac troponin testing in the acute care setting: ordering, reporting, and high sensitivity assays - an update from the Canadian society of clinical chemists (CSCC). Clin Biochem 2011;44:1273-7.
10. Worster A, Devereaux PJ, Heels-Ansdell D, Guyatt GH, Opie J, Mookadam F, Hill SA. Capability of ischemia-modified albumin to predict serious cardiac outcomes in the short term among patients with potential acute coronary syndrome. CMAJ 2005;172:1685-90. (Pubitemid 40896860)
11. Hill SA, Devereaux PJ, Griffith L, Opie J, McQueen MJ, Panju A, et al. Can troponin I measurement predict short-term serious cardiac outcomes in patients presenting to the emergency department with possible acute coronary syndrome? CJEM 2004;6:22-30. (Pubitemid 40632000)
12. Kavsak PA, Ko DT, Newman AM, Palomaki GE, Lustig V, MacRae AR, Jaffe AS. Risk stratification for heart failure and death in an acute coronary syndrome population using inflammatory cytokines and N-terminal pro-brain natriuretic peptide. Clin Chem 2007;53:2112-8. (Pubitemid 350197294)
13. Kavsak PA, Newman AM, Ko DT, Palomaki GE, Lustig V, MacRae AR, Jaffe AS. Is a pattern of increasing biomarker concentrations important for long-term risk stratification in acute coronary syndrome patients presenting early after the onset of symptoms? Clin Chem 2008;54:747-51. (Pubitemid 351573717)
14. Kavsak PA, McQueen MJ. Sensitive and high sensitivity cardiac troponin I concentrations in the Heart Outcomes Prevention Evaluation (HOPE) study - a high risk population. Clin Chim Acta 2010;411:1832.
15. Saenger AK, Beyrau R, Braun S, Cooray R, Dolci A, Freidank H, et al. Multicentre analytical evaluation of a high-sensitivity troponin T assay. Clin Chim Acta 2011;412:748-54.
16. Kavsak PA, Wang X, Ko DT, MacRae AR, Jaffe AS. Short- and long-term risk stratification using a next-generation, high-sensitivity research cardiac troponin I (hs-cTnI) assay in an emergency department chest pain population. Clin Chem 2009;55:1809-15.
17. Zethelius B, Johnston N, Venge P. Troponin I as a predictor of coronary heart disease and mortality in 70-year-old men: a community-based cohort study. Circulation 2006;113:1071-8.
18. Kavsak PA, Newman AM, Lustig V, MacRae AR, Palomaki GE, Ko DT, et al. Long-term health outcomes associated with detectable troponin I concentrations. Clin Chem 2007;53:220-7. (Pubitemid 46343361)
19. Kavsak PA, MacRae AR, Newman AM, Lustig V, Palomaki GE, Ko DT, et al. Effects of contemporary troponin assay sensitivity on the utility of the early markers myoglobin and CKMB isoforms in evaluating patients with possible acute myocardial infarction. Clin Chim Acta 2007;380:213-6. (Pubitemid 46498026)
20. Venge P, Johnston N, Lindahl B, James S. Normal plasma levels of cardiac troponin I measured by the high-sensitivity cardiac troponin I access prototype assay and the impact on the diagnosis of myocardial ischemia. J Am Coll Cardiol 2009;54:1165-72.